SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Improving the Outcome for Patients With Diseases Whose Treatment Requires Ex Vivo Cell Processing, Rice University Study
December 6, 2012
 · 
1 min read
Lone Star Bio
World’s Smallest Wrench Puts a New Twist on Microscopic Manipulation, University of Texas Study
December 4, 2012
 · 
1 min read
Lone Star Bio
Metabolic Protein Launches Sugar Feast That Nurtures Brain Tumors, University of Texas MD Anderson Cancer Center Study
November 27, 2012
 · 
1 min read
Lone Star Bio
Diabetes Drug Improves Memory, University of Texas Medical Branch Study
November 21, 2012
 · 
1 min read
Lone Star Bio
Are Knee Injuries Tied to Menstrual Cycle? University of Texas Study
November 16, 2012
 · 
1 min read
Lone Star Bio
Patients With Aberrations in Two Genes Respond Better to Drugs Blocking a Well-Known Cancer Pathway, MD Anderson Cancer Center Study
November 8, 2012
 · 
1 min read
Lone Star Bio
Texas Biomed Reports Faster, More Economical Method for Detecting Bioterror Threats
November 7, 2012
 · 
1 min read
Lone Star Bio
Tumor-Causing Cells are Squishier, University of Texas MD Anderson Cancer Center Study
November 5, 2012
 · 
1 min read
Lone Star Bio
University of Texas Health Science Center Scientists Step Up Hunt for Bacterial Genes Tied to Lyme Disease
October 26, 2012
 · 
1 min read
Lone Star Bio
Genome Analysis of Pancreas Tumors Reveals New Pathway, Baylor College of Medicine Study
October 25, 2012
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Press Releases
DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy
June 25, 2026
 · 
10 min read
Press Releases
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
June 25, 2026
 · 
7 min read
Press Releases
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
June 25, 2026
 · 
3 min read
Press Releases
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 25, 2026
 · 
5 min read
Press Releases
Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
June 24, 2026
 · 
5 min read
Press Releases
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
June 24, 2026
 · 
5 min read
Press Releases
Susan G. Komen® Awards $15.4 Million In Research Grants to Accelerate Breakthroughs in Breast Cancer Care
June 24, 2026
 · 
6 min read
Load More